Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Latest reported BEAM revenue for 2025-12-31 was $139.7M. Net income was -$80.0M. BEAM currently screens at market cap $2.01B.
Use this BEAM page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BEAM quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BEAM SEC filings page. Lician reads the product cache first so this HTML stays unique to Beam Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full BEAM income, balance, and cash tables.